Consolidated statements of income and comprehensive income
(unaudited)
|
Nine months ended 30 September |
|
(thousands of €, except share and per share data) |
2017 |
2016 |
Revenues |
87,870 |
50,009 |
Other income |
18,484 |
15,031 |
Total revenues and other income |
106,354 |
65,040 |
|
|
|
Research and development expenditure |
(149,226) |
(96,739) |
General and administrative expenses |
(17,783) |
(15,511) |
Sales and marketing expenses |
(1,898) |
(1,272) |
Total operating expenses |
(168,907) |
(113,522) |
|
|
|
Operating loss |
(62,552) |
(48,482) |
|
|
|
Fair value re-measurement of share subscription agreement |
– |
57,479 |
Other financial income |
3,663 |
2,642 |
Other financial expenses |
(26,805) |
(3,500) |
|
|
|
Profit / loss (–) before tax |
(85,694) |
8,138 |
|
|
|
Income taxes |
(161) |
(71) |
|
|
|
Net income / loss (–) |
(85,855) |
8,067 |
Net income / loss (–) attributable to: |
|
|
Owners of the parent |
(85,855) |
8,067 |
Basic income / loss (–) per share |
(1.75) |
0.18 |
Diluted income / loss (–) per share |
(1.75) |
0.17 |
Weighted average number of shares – basic (in thousands of shares) |
48,996 |
45,527 |
Weighted average number of shares – diluted (in thousands of shares) |
48,996 |
47,054 |
|
Nine months ended 30 September |
|
(thousands of €) |
2017 |
2016 |
Net income / loss (–) |
(85,855) |
8,067 |
Items that may be reclassified subsequently to profit or loss: |
|
|
Fair value adjustment of available-for-sale financial assets |
(62) |
(122) |
Translation differences, arisen from translating foreign activities |
(569) |
(816) |
Other comprehensive income, net of income tax |
(631) |
(938) |
|
|
|
Total comprehensive income attributable to: |
|
|
Owners of the parent |
(86,486) |
7,129 |